SW
CMPX icon

Simplicity Wealth’s Compass Therapeutics CMPX Stock Holding History

Simplicity Wealth’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.9K Buy
36,480
+8,130
+29% +$24K ﹤0.01% 997
2026
Q1 		$150K Sell
28,350
-5,519
-16% -$31.9K 0.01% 726
2025
Q4 		$182K Sell
33,869
-3,165
-9% -$14.6K 0.01% 683
2025
Q3 		$130K Sell
37,034
-47,602
-56% -$150K 0.01% 688
2025
Q2 		$220K Buy
84,636
+38,093
+82% +$78.6K 0.01% 560
2025
Q1 		$88.4K Buy
+46,543
New +$124K 0.01% 540
2024
Q2 		– Sell
-40,243
Closed -$79.7K – 1256
2024
Q1 		$79.7K Buy
+40,243
New +$69.5K ﹤0.01% 1122

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Simplicity Wealth's CMPX Position: Q2 2026 in Review

Simplicity Wealth increased its Compass Therapeutics (CMPX) stake by 29% in Q2 2026, buying an estimated $24K and bringing the position to 36,480 shares worth $79.9K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Simplicity Wealth first reported a position in CMPX in Q1 2024 and has held it in 7 quarters since. The position peaked at $220K in Q2 2025. 216 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Simplicity Wealth held 36,480 shares of Compass Therapeutics worth $79.9K as of Q2 2026.
  • Simplicity Wealth bought 8,130 Compass Therapeutics shares in Q2 2026, an estimated $24K.
  • Compass Therapeutics made up ﹤0.01% of Simplicity Wealth's portfolio in Q2 2026, its #997 holding.
  • Simplicity Wealth first reported a position in Compass Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • Simplicity Wealth's Compass Therapeutics position peaked at $220K in Q2 2025.
  • 216 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.